Seaport Therapeutics (NASDAQ:SPTX) reported quarterly earnings results on November 02, 2026 that exceeded analyst expectations.
At publication ·
Seaport Therapeutics (NASDAQ:SPTX) · earnings beat
At a glance
Seaport Therapeutics (NASDAQ:SPTX) reported quarterly earnings results on November 02, 2026 that exceeded analyst expectations.
The company reported earnings per share of $-0.49, beating the consensus estimate of $-0.56 by $0.07 per share. Revenue came in at , meeting the estimate of .
Seaport Therapeutics's stock moved following the earnings release.
Seaport Therapeutics's earnings outperformance reflects execution that exceeded Wall Street's expectations. Earnings beats can lead to upward estimate revisions from analysts, which often correlate with sustained stock price appreciation over the following weeks as models are updated.
The 13% beat relative to consensus estimates is a notable deviation. Earnings surprises of this magnitude often trigger analyst revisions and can influence institutional positioning in the weeks following the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Seaport Therapeutics should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.
| Quarter | EPS Actual | EPS Est. | Surprise |
|---|---|---|---|
| Q3 (Nov 2026) | $-0.49 | $-0.56 | +12.5% |
| Q2 (Aug 2026) | $-1.78 | $-0.60 | -196.7% |
| Q1 (Jun 2026) | $-10.34 | $-10.64 | +2.8% |
Related Tools: Earnings Calendar | View SPTX Stock Page
Check the latest earnings dates on our SPTX earnings page or the Earnings Calendar.
See the full Q3 results including EPS actual vs estimate on our SPTX earnings page.
Current market data
NASDAQ · SPTX
Keep reading
